BerGenBio ASA Correlations

BRRGF Stock  USD 97.09  0.00  0.00%   
The correlation of BerGenBio ASA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

BerGenBio ASA Correlation With Market

Good diversification

The correlation between BerGenBio ASA and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BerGenBio ASA and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to BerGenBio ASA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BerGenBio ASA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BerGenBio ASA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BerGenBio ASA to buy it.

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DOGPSEPSF
PSCBFSEPSF
GHSISEPSF
IPCIFSEPSF
OCTHFSEPSF
IVITFSEPSF
  

High negative correlations

IVITFOCTHF
TRYPFPXMVF
TRYPFFTHWF
PXMVFFTHWF
TRYPFIVITF
PXMVFIVITF

Risk-Adjusted Indicators

There is a big difference between BerGenBio Pink Sheet performing well and BerGenBio ASA Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BerGenBio ASA's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SEPSF  2.90 (1.48) 0.00  12.78  0.00 
 0.00 
 97.21 
PSCBF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GHSI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
IPCIF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
OCTHF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DOGP  5.72 (0.41) 0.00 (0.72) 0.00 
 11.04 
 42.62 
IVITF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
FTHWF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PXMVF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TRYPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Be your own money manager

Our tools can tell you how much better you can do entering a position in BerGenBio ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

BerGenBio ASA Corporate Management

Rune SkeieChief OfficerProfile
Debbie MolyneuxChief OfficerProfile
Nigel MScChief OfficerProfile
Alison MessomDirector OperationsProfile
James BarnesChief OfficerProfile
Cristina MDChief OfficerProfile
Martin OlinChief OfficerProfile